Age-related health care disparities in multiple myeloma
Author:
Affiliation:
1. INSERM CIC 1402, CHU; Poitiers France
2. Registre des Cancers Poitou-Charentes, Faculté de Médecine et Pharmacie; Université de Poitiers; Poitiers France
3. Service d'Onco-Hématologie et Thérapie Cellulaire; CHU de Poitiers; France
Funder
Groupement Interrégional de Recherche Clinique du Grand Ouest
Fondation Université de Poitiers
APEMSA (Association Pictave pour l’Etude des Maladies du Sang)
Publisher
Wiley
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference28 articles.
1. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group;The International Myeloma Working Group*;Br J Haematol,2003
2. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation;Palumbo;Leukemia,2009
3. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report;Palumbo;Blood,2015
4. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group;Palumbo;J Clin Oncol,2015
5. Breast cancer in the elderly: retrospective study on diagnosis and treatment according to national guidelines;Hamaker;Breast J,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system;BMC Cancer;2024-03-05
2. Global disparities in patients with multiple myeloma: a rapid evidence assessment;Blood Cancer Journal;2023-07-18
3. Rates of adherence to cancer treatment guidelines in Australia and the factors associated with adherence: A systematic review;Asia-Pacific Journal of Clinical Oncology;2023-03-07
4. Trial designs and endpoints for immune therapies in multiple myeloma;American Journal of Hematology;2022-11-07
5. Do older patients truly benefit from advances in myeloma care?;Haematologica;2022-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3